Chemical Structure (Spironolactone 01)
Spironolactone Tablet, Film Coated
Product Images NDC 63629-4094
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 63629-4094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Spironolactone 02)
This appears to be a clinical trial result comparing the effectiveness of spironolactone versus a placebo in some medical condition, possibly represented on a graph with time in months on the x-axis and probability or some other measure of effectiveness on the y-axis. The log-rank p-value suggests a statistically significant difference between the two treatments. No further information is available.*
Figure 2 (Spironolactone 03)
Label Image (Lbl636294094)
This is a description of Spironolactone Mo 100mg Tablets. These tablets are packaged by Begane Ranch Bukank and compare to Aldactone 100mg Tablets by Mutual Pharma Inc. The tablets should be stored at room temperature and patients should follow their doctor's instructions. The package contains 100 tablets and has an expiration date of MM/YY with an NDC number of 6362940941 040941103492.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
